Last reviewed · How we verify

DT2216

Dialectic Therapeutics, Inc · Phase 1 active Small molecule

At a glance

Generic nameDT2216
Also known asC77H96ClF3N10O10S4
SponsorDialectic Therapeutics, Inc
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.